The Effect of Intraportal Prostaglandin E1 on Adhesion Molecule Expression, Inflammatory Modulator Function, and Histology in Canine Hepatic Ischemia/Reperfusion Injury

Journal of Surgical Research

Volumn 138, Issue 1, 2007, Pages 88-99

  Hafez, Tariq ^a   Moussa, Mona ^b   Nesim, Iris ^b   Baligh, Nadia ^b   Davidson, Brian ^a   Abdul Hadi, Ahmed ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Imbaba   (Egypt)

Author keywords

adhesion; alprostadil; electron microscopy ultrastructure; endothelial cell; leukocyte

Indexed keywords

AMINOTRANSFERASE; CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PROSTAGLANDIN E1; RINGER SOLUTION; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; DOG; ELECTRON MICROSCOPY; FEMALE; HEPATIC ARTERY; HISTOPATHOLOGY; LAPAROTOMY; LIVER BIOPSY; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MALE; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

ALPROSTADIL; ANIMALS; BIOPSY; CELL ADHESION MOLECULES; DOGS; E-SELECTIN; FEMALE; HEPATOCYTES; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; LIVER; MALE; MICROSCOPY, ELECTRON; P-SELECTIN; PORTAL VEIN; REPERFUSION INJURY; VASCULAR CELL ADHESION MOLECULE-1; VASODILATOR AGENTS;

EID: 33846887853     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.009     Document Type: Article

References (50)

1. Kupiec-Weglinski J.W., and Busuttil R.W. Ischemia and reperfusion injury in liver transplantation. Transplant Proc 37 (2005) 1653
2. Olthoff K.M. Can reperfusion injury of the liver be prevented?. Trying to improve on a good thing. Pediatr Transplant 5 (2001) 390
3. Sinclair S., and Levy G. Eicosanoids and the liver. Ital J Gastroenterol 22 (1990) 205
4. Himmelreich G., Hundt K., Neuhaus P., Bechstein W.O., Roissant R., and Riess H. Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 55 (1993) 819
5. Seo K.Y., Chung K.Y., Kim Y.S., Moon I.H., and Choi K.J. Effect of lipo-PGE1 on ischemia-reperfusion injury and endothelin-1 concentrations after canine partial liver transplantation. Transplant Proc 35 (2003) 122
6. Morioka D., Kubota T., Sekido H., et al. Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation. Liver Transpl 9 (2003) 79
7. Izuishi K., Fujiwara M., Hossain M.A., Okano K., Usuki H., and Maeta H. Protective effect of intraportal prostaglandin E1 on prolonged cold preserved rat liver. Transplant Proc 35 (2003) 130
8. Weiss J.M., Pilarski K.A., Weyl A., et al. Prostaglandin E1 inhibits TNF alpha-induced T-cell adhesion to endothelial cells by selective down-modulation of ICAM-1 expression on endothelial cells. Exp Dermatol 4 (1995) 302
9. Natori S., Fujii Y., Kurosawa H., Nakano A., and Shimada H. Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 64 (1997) 1514
10. Iwata K., Shimazu M., Wakabayashi G., Ohshima A., Yoshida M., and Kitajima M. Intraportal perfusion of prostaglandin E1 attenuates hepatic postischaemic microcirculatory impairments in rats. J Gastroenterol Hepatol 14 (1999) 634
11. Hossain M.A., Hamamoto I., Wakabayashi H., et al. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy. Br J Surg 86 (1999) 776
12. Yang H., Majno P., Morel P., et al. Prostaglandin E(1) protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64 (2002) 94
13. Henley K.S., Lucey M.R., Normolle D.P., et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology 21 (1995) 366
14. Klein A.S., Cofer J.B., Pruett T.L., et al. Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial. Gastroenterology 111 (1996) 710
15. Radovancevic B., Vrtovec B., Thomas C.D., et al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. J Heart Lung Transplant 24 (2005) 690
16. de Perrot M., Fischer S., Liu M., Jin R., Bai X.H., Waddell T.K., and Keshavjee S. Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: A shift from pro- to anti-inflammatory cytokines. Transplantation 72 (2001) 1505
17. Suehiro T., Shimada M., Kishikawa K., et al. Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation. Transpl Int 18 (2005) 923
18. Golub M., Zia P., Matsuno M., and Horton R. Metabolism of prostaglandins A1 and E1 in man. J Clin Invest 56 (1975) 1404
19. Totsuka E., Sasaki M., Takahashi K., et al. The effects of intraportal prostaglandin E1 administration on hepatic warm ischemia and reperfusion injury in dogs. Surg Today 25 (1995) 421
20. Sato T., Kato T., Kurokawa T., et al. Continuous infusion of prostaglandin E1 via the superior mesenteric artery can prevent hepatic injury in hepatic artery interruption through passive portal oxygenation. Liver 20 (2000) 179
21. Tsujisaki M., Imai K., Hirata H., et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 85 (1991) 3
22. Wilasrusmee C., Siritheptawee S., Kanchanapanjapon S., et al. Ultrastructural changes in cirrhotic and noncirrhotic patients due to hepatectomy. J Hepatobiliary Pancreat Surg 11 (2004) 266
23. Fung K.M., Messing A., Lee V.M., and Trojanowski J.Q. A novel modification of the avidin-biotin complex method for immunohistochemical studies of transgenic mice with murine monoclonal antibodies. J Histochem Cytochem 40 (1992) 1319
24. Marks J.R., Humphrey P.A., Wu K., et al. Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219 (1994) 332
25. Currin R.T., Reinstein L.J., Lichtman S.N., Thurman R.G., and Lemasters J.J. Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury. Transplant Proc 25 (1993) 1631
26. Lemasters J.J., and Thurman R.G. The many facets of reperfusion injury. Gastroenterology 108 (1995) 1317
27. Sugawara Y., Kubota K., Ogura T., Esumi H., Inoue K., Takayama T., and Makuuchi M. Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: Results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol 29 (1998) 969
28. Horie Y., and Ishii H. Liver dysfunction elicited by gut ischemia-reperfusion. Pathophysiology 8 (2001) 11
29. Urata K., Nguyen B., Brault A., Lavoie J., Rocheleau B., and Huet P.M. Decreased survival in rat liver transplantation with extended cold preservation: Role of portal vein clamping time. Hepatology 28 (1998) 366
30. Kawachi S., Shimazu M., Wakabayashi G., et al. Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation. Transplantation 64 (1997) 205
31. Moussa M.E., Sarraf C.E., Uemoto S., Sawada H., and Habib N.A. Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure. Liver Transpl Surg 2 (1996) 461
32. Shimada M., Kajiyama K., Hasegawa H., et al. Role of adhesion molecule expression and soluble fractions in hepatic resection. J Am Coll Surg 186 (1998) 534
33. Pigott R., Dillon L.P., Hemingway I.H., and Gearing A.J. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187 (1992) 584
34. Marchesi S., Pasqualini L., Lombardini R., et al. Prostaglandin E1 improves endothelial function in critical limb ischemia. J Cardiovasc Pharmacol 41 (2003) 249
35. Maurus C.F., Schmidt D., Schneider M.K., Turina M.I., Seebach J.D., and Zund G. Hypoxia and reoxygenation do not upregulate adhesion molecules and natural killer cell adhesion on human endothelial cells in vitro. Eur J Cardiothorac Surg 23 (2003) 976
36. McEver R.P. GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 45 (1991) 156
37. Gianetti J., De Caterina M., De Cristofaro T., Ungaro B., Guercio R.D., and De Caterina R. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 142 (2001) 733
38. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191
39. Woollard K.J. Soluble bio-markers in vascular disease: Much more than gauges of disease?. Clin Exp Pharmacol Physiol 32 (2005) 233
40. El-Wahsh M., Seifalian A.M., Fuller B.J., Rolles K., and Davidson B.R. Induction of adhesion molecule expression in liver ischaemia-reperfusion injury is associated with impaired hepatic parenchymal microcirculation. Br J Surg 91 (2004) 1034
41. Colletti L.M., Cortis A., Lukacs N., Kunkel S.L., Green M., and Strieter R.M. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 10 (1998) 182
42. Essani N.A., Bajt M.L., Farhood A., Vonderfecht S.L., and Jaeschke H. Transcriptional activation of vascular cell adhesion molecule-1 gene in vivo and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J Immunol 158 (1997) 5941
43. Lou J., Buhler L., Deng S., Mentha G., Montesano R., Grau G.E., and Morel P. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 27 (1998) 822
44. Tedder T.F., Steeber D.A., Chen A., and Engel P. The selectins: Vascular adhesion molecules. FASEB J 9 (1995) 866
45. Lindemann S., Gierer C., and Darius H. Prostacyclin inhibits adhesion of polymorphonuclear leukocytes to human vascular endothelial cells due to adhesion molecule independent regulatory mechanisms. Basic Res Cardiol 98 (2003) 8
46. Kanemitsu S., Nishikawa M., Onoda K., et al. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation. J Thorac Cardiovasc Surg 126 (2003) 428
47. Weller A., Isenmann S., and Vestweber D. Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem 267 (1992) 15176
48. Helling T.S., Wogahn B.M., Olson S.A., Evans L.S., Reddy B.R., and VanWay III C. The effect of prostaglandin E1 on liver adenine nucleotides and cytoplasmic enzymes in a porcine model of normothermic hepatic ischemia. Hepatology 22 (1995) 1554
49. Pober J.S., Slowik M.R., De Luca L.G., and Ritchie A.J. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 150 (1993) 5114
50. Sato T., Asanuma Y., Hashimoto M., et al. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure-report of a case. Hepatogastroenterology 47 (2000) 846